慢病毒属,lentivirus
1)lentivirus[英]['lenti,vai?r?s][美]['l?nt?,va?r?s]慢病毒属
2)lentivirus/GE慢病毒属/遗传学
3)lentivirus[英]['lenti,vai?r?s][美]['l?nt?,va?r?s]慢病毒
1.Overexpression of lentivirus-mediated glial cell line-derived neurotrophic factor in bone marrow stromal cells and its neuroprotection for the PC12 cells damaged by lactacystin;慢病毒介导的胶质细胞系源性神经营养因子在骨髓基质细胞中的表达及其对乳胞素干预PC12细胞的保护作用(英文)
2.Construction of lentivirus producing PLC-γ1 siRNA and its effect on apoptosis of human colorectal carcinomas cell lines;稳定表达PLCγ1 siRNA慢病毒的构建及对人大肠癌细胞凋亡的影响
3.Construction and identification of a recombinant lentivirus harboring RNAi targeting rat Nogo receptor gene;大鼠Nogo受体基因RNA干扰慢病毒载体的构建与鉴定
英文短句/例句

1.NR2B Lentivirus Vector Construction and Lentivirus Production;NR2B慢病毒载体构建和病毒生产
2.Construction and expression of pLenti6/V5-R-K with CC-intrakineRANTES-K慢病毒载体的构建及其慢病毒的产生和鉴定
3.The Construction and Expression of Lentivirus-Mash1 Expressing Vector;重组Mash1慢病毒表达载体的构建及表达
4.Construction of Recombinant Porcine Sox2 and Nanog Lentiviral Vector猪Sox2和Nanog慢病毒表达载体的构建
5.Construction of Recombinant Porcine pLL-Myc and pLL-Klf4 Lentiviral Vector猪慢病毒载体pLL-Myc和pLL-Klf4的构建
6.Construction and Identification of Lentiviral Expression Vector Carrying Dnd1Dnd1慢病毒表达载体的制备及鉴定
7.Construction and Identification of RECK Gene Recombinant Lentiviral VectorRECK基因重组慢病毒载体的构建与鉴定
8.Construction and identification of lentiviral vector of RNA interference of TIEG geneTIEG特异的siRNA慢病毒载体的构建及鉴定
9.Construction of recombinant lentiviral vector expressing HCV core-Ant表达HCV core-Ant的重组慢病毒的构建
10.Construction and Expression of pir-b Gene Lentiviral VectorPir-b基因慢病毒载体的构建和表达
11.Advance in RNAi Mediated with Lentivirus-based Vectors慢病毒载体介导RNAi的研究进展
12.Construction and identification of lentiviral vector of RNA interference of CDC25B3 geneCDC25B_3基因RNAi慢病毒载体的构建与鉴定
13.Construction and Identification of pWPXL-EGFP-IRES-hTfR Lentivirus VectorpWPXL-EGFP-IRES-hTfR慢病毒载体的构建和鉴定
14.Construction and identification of lentiviral vector-mediated RNA interference of SATB1 geneSATB1基因RNAi慢病毒载体的构建与鉴定
15.Construction and Identification of a Lentiviral Vector Expressing shRNA Targeting Human notch1 Gene人notch1-shRNA慢病毒表达载体的构建与鉴定
16.Construction and identification of lentiviral vector encoding shRNA against Smad3Smad3基因RNAi慢病毒载体的构建与鉴定
17.The Construction of High-efficiency Packaging System of the 3~(rd) Lentivirus第三代慢病毒高效率包装系统的建立
18.Formaldehyde slowly inactivates many viruses.甲醛能慢慢使多种病毒失去活性。
相关短句/例句

lentivirus/GE慢病毒属/遗传学
3)lentivirus[英]['lenti,vai?r?s][美]['l?nt?,va?r?s]慢病毒
1.Overexpression of lentivirus-mediated glial cell line-derived neurotrophic factor in bone marrow stromal cells and its neuroprotection for the PC12 cells damaged by lactacystin;慢病毒介导的胶质细胞系源性神经营养因子在骨髓基质细胞中的表达及其对乳胞素干预PC12细胞的保护作用(英文)
2.Construction of lentivirus producing PLC-γ1 siRNA and its effect on apoptosis of human colorectal carcinomas cell lines;稳定表达PLCγ1 siRNA慢病毒的构建及对人大肠癌细胞凋亡的影响
3.Construction and identification of a recombinant lentivirus harboring RNAi targeting rat Nogo receptor gene;大鼠Nogo受体基因RNA干扰慢病毒载体的构建与鉴定
4)lentiviral vector慢病毒
1.The Experimental Study on Re-construction of Corneal Surface Layer by Using Human Amniotic Epithelial Cells Transfered with hTERT Gene Mediated by Lentiviral Vector慢病毒载体介导hTERT基因修饰的人羊膜上皮细胞重建角膜表层的实验研究
2.Detection of BDNF expression after injection of BDNF gene lentiviral vector in rat hippocampus大鼠海马脑区脑源性神经营养因子慢病毒注射与表达的检测
3.The constructed lentiviral vector was identified by PCR and DNA sequencing,and w.目的构建特异性沉默CyPA基因的慢病毒颗粒,体外观察其对非小细胞肺癌H1299细胞生长的影响。
5)XPAXPA慢病毒
6)lentiviral vector慢病毒载体
1.Empirical study of the lentiviral vectors expessing siRNA for survivin gene on tumor inhibition of A549 cells tumor-bearingnude mice;慢病毒载体介导siRNA对裸鼠移植人肺腺癌A549抑瘤作用的实验研究
2.Construction and identification of TAT-BACEsp-GFP triple fusion gene expressed from recombinant lentiviral vector;TAT-BACEsp-GFP三融合基因慢病毒载体的构建与鉴定
3.Cloning of human CCR5Delta32 gene and construction of the recombinant lentiviral vector pLenti-CCR5Delta32;人CCR5Delta32基因的克隆及其重组慢病毒载体的构建
延伸阅读

慢病毒感染  一类潜伏期长(可长达数月至数年)、起病隐袭、病程长并进行性加重,甚至可致死的疾病。又称慢感染。病变多发生于中枢神经系统,弥散分布,预后差,无特效治疗。